相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
CD274
- 级别:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 目录编号:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 克隆性:
单克隆
- 抗原来源:
大鼠
- 保质期:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 抗体英文名:
Brilliant Violet 421™ anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 抗体名:
CD274 (B7-H1, PD-L1) 抗体
- 标记物:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 宿主:
大鼠
- 适应物种:
小鼠
- 免疫原:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 亚型:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 形态:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 应用范围:
FC
- 保存条件:
2-8℃
- 浓度:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 规格:
125 uL
Brilliant Violet 421™ anti-mouse CD274 (B7-H1, PD-L1) Antibody详细如下:
Description :CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type Itransmembrane protein and a member of the B7 family within the immunoglobulin receptorsuperfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activatedendothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1with PD-1 plays an important role in the inhibition of T cell responses. Other studies haveshown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 isinvolved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, inan IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cellproliferation and cytokine production.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation :The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™under optimal conditions.
Concentration :Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent betitrated for optimal performance for each application.
Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.
Excitation Laser :Violet Laser (405 nm)
Description :CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type Itransmembrane protein and a member of the B7 family within the immunoglobulin receptorsuperfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activatedendothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1with PD-1 plays an important role in the inhibition of T cell responses. Other studies haveshown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 isinvolved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, inan IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cellproliferation and cytokine production.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation :The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™under optimal conditions.
Concentration :Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent betitrated for optimal performance for each application.
Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.
Excitation Laser :Violet Laser (405 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Maier H, et al. 2007. J. Immunol. 178:2714.
2. Meng Q, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:4444. PubMed
3. Scarlett UK, et al. 2012. J Exp Med. 209:495. PubMed
4. Grabie N, et al. 2007. Circulation 116:2062. (IF, IHC)
5. Paterson AM, et al. 2011. J. Immunol. 187:1097.
6. Channappanavar R, et al. 2012. PLoS One 7:e39757. (Block)
7. Schreiber HA, et al. 2010. PLoS One 5:e11453. (Block) PubMed
8. Muthumani K, et al. 2011. J. Immunol. 187:2932. (Block) PubMed
9. Cripps JG, et al. 2010. Hepatology 52:1350. (Block) PubMed
10. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
11. Riella LV, et al. 2011. Am. J. Transplant 11:832-40. (IHC)
12. Lei GS, et al. 2015. Infect Immun. 83:572. PubMed
Product Citations:
1. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
2. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
3. Wei H, et al. 2021. Malar J. 20:89. PubMed
4. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
5. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
6. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
7. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
8. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
9. Giesen D, et al. 2020. Clin Cancer Res. 26:3999. PubMed
10. Walsh SM, et al. 2021. eLife. 10:00. PubMed
11. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
12. Yu D, et al. 2019. Cell Commun Signal. 0.828472222. PubMed
1. Maier H, et al. 2007. J. Immunol. 178:2714.
2. Meng Q, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:4444. PubMed
3. Scarlett UK, et al. 2012. J Exp Med. 209:495. PubMed
4. Grabie N, et al. 2007. Circulation 116:2062. (IF, IHC)
5. Paterson AM, et al. 2011. J. Immunol. 187:1097.
6. Channappanavar R, et al. 2012. PLoS One 7:e39757. (Block)
7. Schreiber HA, et al. 2010. PLoS One 5:e11453. (Block) PubMed
8. Muthumani K, et al. 2011. J. Immunol. 187:2932. (Block) PubMed
9. Cripps JG, et al. 2010. Hepatology 52:1350. (Block) PubMed
10. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
11. Riella LV, et al. 2011. Am. J. Transplant 11:832-40. (IHC)
12. Lei GS, et al. 2015. Infect Immun. 83:572. PubMed
Product Citations:
1. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
2. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
3. Wei H, et al. 2021. Malar J. 20:89. PubMed
4. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
5. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
6. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
7. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
8. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
9. Giesen D, et al. 2020. Clin Cancer Res. 26:3999. PubMed
10. Walsh SM, et al. 2021. eLife. 10:00. PubMed
11. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
12. Yu D, et al. 2019. Cell Commun Signal. 0.828472222. PubMed
文献支持
Brilliant Violet 421™ 抗小鼠 CD274 (B7-H1, PD-L1) 抗体
¥3700










